TGFBR2 and cancer: Thus, under the cooperation of TGFβR2, CDKN1A and RAD21, the inhibition of DNA synthesis and the repair of DNA damage result in allowing cells to survival with the burden of potentially lethal cisplatin-induced cytotoxicity, and then cancer cells become resistant to cisplatin.